dpp4 vs sglt2 vs glp-1 Series Part 1: Utilization drives decline in DPP-4 inhibitors, increase in SGLT2s among competitive drug classes ada guidelines dpp4 and glp

As of August 2025, the Food and Drug Administration (FDA) approved generic liraglutide injections for weight management, the same active ingredient as in brand-name Saxenda

Validation of administrative osteoarthritis diagnosis using a clinical and radiological population-based cohort

Second, his allodynia initially resolved spontaneously after two weeks, then recurred six months later in a severe episode after antibiotic treatment

This effect is achieved by reducing the expression of Trem2 and NFATc1 and downregulating the expression of CTSK and TRAP to inhibit bone resorption activity

Author contributions Andr J